在慢性缺氧诱导的心脏改造时,需要阿尔法-谷氨酸
Daishi Tang1, Yong Gu1, Shasha Chen2
1Digestive System Department, Shaanxi Provincial Crops Hospital of Chinese People's Armed Police Force, Xi'an, People's Republic of China.
American journal of physiology. Cell physiology
|July 29, 2024
概括
慢性缺氧会通过增加α-谷氨酸 (α-KG) 引起心脏缩. 这种代谢物驱动用于心脏重塑的基因转录,将代谢变化与心脏病联系起来.
科学领域:
- 心血管生物学 心血管生物学
- 代谢调节 代谢调节 代谢调节
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 慢性缺氧 (CH) 与心血管疾病有关,尤其是心脏缩.
- 代谢重塑发生在缺氧心脏中,但其与缩的联系尚不清楚.
研究的目的:
- 研究慢性缺氧中代谢重塑和心脏缩之间的机械联系.
- 确定α-谷氨酸 (α-KG) 在缺氧引起的心脏变化的作用.
主要方法:
- 使用的野生型C57BL/6J小鼠接受了4周的CH.
- 使用心声学和形态学分析评估心脏影响.
- 测量心脏α-KG含量并操纵其降解;沉默KDM5酶.
主要成果:
- CH诱导显著的心脏缩而没有改变心脏功能.
- 在CH心脏中观察到心脏α-KG的升高.
- 促进α-KG降解可以防止缩,但会导致功能障碍.
- α-KG通过通过基因素甲基化促进了与缩相关的基因转录,涉及KDM5.5.
结论:
- α-KG对于CH诱导的心脏重塑至关重要.
- 这项研究弥合了代谢中间体和缺氧心脏中的心脏重塑之间的理解.
- α-KG将代谢变化与驱动心脏缩的表观遗传修饰联系在一起.
相关概念视频
Acute Respiratory Failure-II
192
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
192
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
192


